Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal for ImmunoTherapy of CancerBusiness Wire • 11/02/21
Bicycle Therapeutics Announces Expansion of Genentech Immuno-Oncology CollaborationBusiness Wire • 10/26/21
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional SharesBusiness Wire • 10/18/21
Bicycle Therapeutics Announces Pricing of Upsized Public Offering of $175 Million of American Depositary SharesBusiness Wire • 10/13/21
Bicycle Therapeutics Announces Proposed $125,000,000 Public Offering of American Depositary SharesBusiness Wire • 10/12/21
Bicycle Therapeutics Stock Falls After Interim Data Of Toxin Conjugates In Ovarian Cancer TrialBenzinga • 10/07/21
Bicycle Therapeutics Announces Interim BT5528 Phase I Clinical Trial Results and Preliminary Results from Ongoing BT8009 Phase I Clinical TrialBusiness Wire • 10/07/21
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Surges 7%: Is This an Indication of Further Gains?Zacks Investment Research • 10/04/21
Bicycle Therapeutics to Present BT5528 Interim Phase I Data at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer TherapeuticsBusiness Wire • 09/30/21
Bicycle Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateBusiness Wire • 08/05/21
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Is a Great Choice for "Trend" Investors, Here's WhyZacks Investment Research • 07/23/21
Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technologyPRNewsWire • 07/13/21
Bicycle Therapeutics Enters Exclusive License and Collaboration Agreement with Ionis to Develop Targeted Oligonucleotide TherapeuticsBusiness Wire • 07/13/21
Here's What Could Help Bicycle Therapeutics PLC Sponsored ADR (BCYC) Maintain Its Recent Price StrengthZacks Investment Research • 07/07/21
Bicycle Therapeutics Announces Restrictions on Shareholder Attendance at Annual General Meeting to be Held on June 28, 2021Business Wire • 06/15/21
Bicycle Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate UpdateBusiness Wire • 05/06/21